KSA Vision 2030 Aligned

Bridging Elite Science, Regulatory Strategy & AI Innovation.

We act as the Virtual Preclinical Department for MENA biotechs. We de-risk drug development, ensure SFDA/ICH compliance, and train clinical teams to leverage AI.

Partner With Us Email Us directly

SFDA

Regulatory Insider Expertise

AI-Driven

Clinical Trial Optimization

Imperial

World-Class Pharmacology Pedigree

Our Expertise

Tailored Solutions for the Asset Lifecycle

From early-stage pharmacological validation to clinical AI deployment, we provide bespoke intelligence and strategic auditing.

Preclinical Regulatory Auditing

We perform rigorous gap analysis and study design auditing against SFDA, ICH, and ISO guidelines to prevent costly IND/CTA rejections before they happen.

Clinical Trials AI Integration

We upskill clinical teams, deploying specialized training modules to help pharmaceutical organizations safely integrate AI and LLMs into trial design and regulatory workflows.

Molecular Pharmacology Strategy

Bespoke scientific advisory focusing on complex GPCR signaling, target safety, and mechanisms of action to bridge the gap between discovery and clinical viability.

Dr. Mohammed Safar

Leadership

Dr. Mohammed Safar

Founder & Principal Consultant (PharmB, MSc, PhD, FHEA)

Dr. Safar provides Roaa Biomedical with an unparalleled dual-vantage point: the Innovator and the Regulator.

  • The Regulator: Scientific Consultant for the Saudi Food and Drug Authority (SFDA), directly guiding regulatory strategy and validating preclinical safety data for the KSA market.
  • The Innovator: Postdoctoral Research Associate at Imperial College London, specializing in novel GPCR drug development.
  • The AI Integrator: Expert in upskilling clinical teams to leverage artificial intelligence for trial optimization and data synthesis.

Ready to de-risk your development pipeline?

Whether you need an SFDA compliance audit, advanced pharmacological strategy, or AI integration training for your clinical team, we are ready to partner with you.

Reach out to us directly to initiate a conversation:

m.safar@roaa.co.uk